B. Sebok et al., ANTIPROLIFERATIVE AND CYTOTOXIC PROFILES OF ANTIPSORIATIC FUMARIC-ACID DERIVATIVES IN KERATINOCYTE CULTURES, European journal of pharmacology. Environmental toxicology and pharmacology section, 270(1), 1994, pp. 79-87
Oral administration with complex mixtures of fumaric acid derivatives
is known to have antipsoriatic efficacy. The present studies aimed to
clarify the mode of action and toxicity of the individual compounds. H
yperproliferative HaCaT keratinocytes in monolayer cultures were expos
ed to fumaric acid, dimethylfumarate, zinc monoethylfumarate, calcium
monoethylfumarate and magnesium monoethylfumarate at concentrations be
tween 0.4 mu M and 960 mu M for 48 h. Cell proliferation was studied b
y [H-3]thymidine incorporation. In addition C-14-labelled amino acid u
ptake and total protein content were measured. Direct cytotoxicity was
determined by the release of cytoplasmic lactate dehydrogenase (LDH)
into the culture medium. The corresponding 50% inhibition concentratio
ns (IC50) were calculated for DNA/ protein synthesis: 2.3/2.5 mu M (di
methylfumarate), 133/145 mu M (zinc monoethylfumarate), 215/230 mu M (
calcium monoethylfumarate), 275/270 mu M (magnesium monoethylfumarate)
, > 960/ > 960 mu M (fumaric acid). The total protein content was less
sensitive. Antiproliferative activity was found for dimethylfumarate
and to a lesser degree for calcium monoethylfumarate already at the su
btoxic concentrations of 1.3 and 4 mu M, respectively. In the case of
magnesium monoethylfumarate, zinc monoethylfumarate and fumaric acid t
here was no such dissociation between their cytotoxic and antiprolifer
ative potential. These data indicate that most of the antipsoriatic po
tential of fumaric therapies is due to the dimethylfumarate compound.